514 related articles for article (PubMed ID: 34255907)
1. Mucormycosis and COVID-19: An epidemic within a pandemic in India.
Selarka L; Sharma S; Saini D; Sharma S; Batra A; Waghmare VT; Dileep P; Patel S; Shah M; Parikh T; Darji P; Patel A; Goswami G; Shah A; Shah S; Lathiya H; Shah M; Sharma P; Chopra S; Gupta A; Jain N; Khan E; Sharma VK; Sharma AK; Chan ACY; Ong JJY
Mycoses; 2021 Oct; 64(10):1253-1260. PubMed ID: 34255907
[TBL] [Abstract][Full Text] [Related]
2. Long-term Outcome of Coronavirus Disease-associated Mucormycosis: 1-year Follow-up Study from India.
Agrawal P; Singh AP; Chakotiya PS; Kumar V; Gautam A; Kumar D
J Assoc Physicians India; 2024 Jun; 72(6):44-48. PubMed ID: 38881134
[TBL] [Abstract][Full Text] [Related]
3. COVID associated mucormycosis: A preliminary study from a dedicated COVID Hospital in Delhi.
Meher R; Wadhwa V; Kumar V; Shisha Phanbuh D; Sharma R; Singh I; Rathore PK; Goel R; Arora R; Garg S; Kumar S; Kumar J; Agarwal M; Singh M; Khurana N; Sagar T; Manchanda V; Saxena S
Am J Otolaryngol; 2022; 43(1):103220. PubMed ID: 34547717
[TBL] [Abstract][Full Text] [Related]
4. Mucormycosis in patients with COVID-19: A cross-sectional descriptive multicentre study from Iran.
Pakdel F; Ahmadikia K; Salehi M; Tabari A; Jafari R; Mehrparvar G; Rezaie Y; Rajaeih S; Alijani N; Barac A; Abdollahi A; Khodavaisy S
Mycoses; 2021 Oct; 64(10):1238-1252. PubMed ID: 34096653
[TBL] [Abstract][Full Text] [Related]
5. COVID-19-associated mucormycosis: Evidence-based critical review of an emerging infection burden during the pandemic's second wave in India.
Aranjani JM; Manuel A; Abdul Razack HI; Mathew ST
PLoS Negl Trop Dis; 2021 Nov; 15(11):e0009921. PubMed ID: 34793455
[TBL] [Abstract][Full Text] [Related]
6. COVID-19-associated mucormycosis, diabetes and steroid therapy: Experience in a single centre in Western Mexico.
Guzmán-Castro S; Chora-Hernandez LD; Trujillo-Alonso G; Calvo-Villalobos I; Sanchez-Rangel A; Ferrer-Alpuin E; Ruiz-Jimenez M; Corzo-Leon DE
Mycoses; 2022 Jan; 65(1):65-70. PubMed ID: 34674319
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for COVID-19 associated mucormycosis in India: A case control study.
Patel AK; Bakshi H; Shah K; Patel S; Patel T; Patel K; Patel KK
Med Mycol; 2022 Jul; 60(7):. PubMed ID: 35709394
[TBL] [Abstract][Full Text] [Related]
8. Diabetes, COVID 19 and mucormycosis: Clinical spectrum and outcome in a tertiary care medical center in Western India.
Mishra Y; Prashar M; Sharma D; Akash ; Kumar VP; Tilak TVSVGK
Diabetes Metab Syndr; 2021; 15(4):102196. PubMed ID: 34246939
[TBL] [Abstract][Full Text] [Related]
9. COVID-19 associated multisystemic mucormycosis from India: a multicentric retrospective study on clinical profile, predisposing factors, cumulative mortality and factors affecting outcome.
Sahu M; Shah M; Mallela VR; Kola VR; Boorugu HK; Punjani AAR; Kumar RV; Kumar S; Manusrut M; Kumar SCR; Rathod R; Babu DM; Gonuguntla HK; Yedlapati GK; Mallu GR; Reddy YS; Reddy VV; Alwala S; Bongu VK; Kamalesh A; Kumar RNK; Jaishetwar GS; Bagapally RS; Srinivas JS; Balasubramaniam A; Rajagopalan BK; Pullikanti B; Prakasham SP; Nimmala P; Nagaraju B; Sahoo PR;
Infection; 2023 Apr; 51(2):407-416. PubMed ID: 35922704
[TBL] [Abstract][Full Text] [Related]
10. Rampant Increase in Cases of Mucormycosis in India and Pakistan: A Serious Cause for Concern during the Ongoing COVID-19 Pandemic.
Ghazi BK; Rackimuthu S; Wara UU; Mohan A; Khawaja UA; Ahmad S; Ahmad S; Hasan MM; Dos Santos Costa AC; Ahmad S; Essar MY
Am J Trop Med Hyg; 2021 Aug; 105(5):1144-1147. PubMed ID: 34460426
[TBL] [Abstract][Full Text] [Related]
11. COVID-19 associated mucormycosis: A Descriptive Multisite Study from India.
Gupta R; Kesavadev J; Krishnan G; Agarwal S; Saboo B; Shah M; Mittal A; Durani S; Luthra A; Singhal A; Rasheed M; Rao GVS; Tripathi V; Jha A; Ghosh A; Mohan V; Singh AK; Phatak S; Panicker J; Bhadada SK; Joshi S; Pal R; Mithal A; Vikram N; Misra A
Diabetes Metab Syndr; 2021; 15(6):102322. PubMed ID: 34717135
[TBL] [Abstract][Full Text] [Related]
12. Mucor in a Viral Land: A Tale of Two Pathogens.
Sen M; Lahane S; Lahane TP; Parekh R; Honavar SG
Indian J Ophthalmol; 2021 Feb; 69(2):244-252. PubMed ID: 33463566
[TBL] [Abstract][Full Text] [Related]
13. Risk factors and outcomes of COVID associated mucormycosis in kidney transplant recipients.
Bansal SB; Rana A; Babras M; Yadav D; Jha P; Jain M; Sethi SK
Transpl Infect Dis; 2022 Apr; 24(2):e13777. PubMed ID: 34932870
[TBL] [Abstract][Full Text] [Related]
14. Mucormycosis an added burden to Covid-19 Patients: An in-depth systematic review.
Shah NN; Khan Z; Ahad H; Elderdery AY; Alomary MN; Atwah B; Alhindi Z; Alsugoor MH; Elkhalifa AME; Nabi S; Bashir SM; Yaqub T; Rather GA; Ansari MA
J Infect Public Health; 2022 Nov; 15(11):1299-1314. PubMed ID: 36279686
[TBL] [Abstract][Full Text] [Related]
15. The double-edged sword of systemic corticosteroid therapy in viral pneumonia: A case report and comparative review of influenza-associated mucormycosis versus COVID-19 associated mucormycosis.
Ahmadikia K; Hashemi SJ; Khodavaisy S; Getso MI; Alijani N; Badali H; Mirhendi H; Salehi M; Tabari A; Mohammadi Ardehali M; Kord M; Roilides E; Rezaie S
Mycoses; 2021 Aug; 64(8):798-808. PubMed ID: 33590551
[TBL] [Abstract][Full Text] [Related]
16. COVID-19 associated mucormycosis - An emerging threat.
Chao CM; Lai CC; Yu WL
J Microbiol Immunol Infect; 2022 Apr; 55(2):183-190. PubMed ID: 35074291
[TBL] [Abstract][Full Text] [Related]
17. Rhino-orbital-cerebral mucormycosis: fungal epidemic in a viral pandemic.
Chouhan M; Solanki B; Shakrawal N
J Laryngol Otol; 2021 Nov; 135(11):981-986. PubMed ID: 34470691
[TBL] [Abstract][Full Text] [Related]
18. Case Report: Rhino-orbital Mucormycosis Related to COVID-19: A Case Series Exploring Risk Factors.
Aggarwal SK; Kaur U; Talda D; Pandey A; Jaiswal S; Kanakan A; Singh A; Chakrabarti SS
Am J Trop Med Hyg; 2021 Dec; 106(2):566-570. PubMed ID: 34902834
[TBL] [Abstract][Full Text] [Related]
19. Multicenter Epidemiologic Study of Coronavirus Disease-Associated Mucormycosis, India.
Patel A; Agarwal R; Rudramurthy SM; Shevkani M; Xess I; Sharma R; Savio J; Sethuraman N; Madan S; Shastri P; Thangaraju D; Marak R; Tadepalli K; Savaj P; Sunavala A; Gupta N; Singhal T; Muthu V; Chakrabarti A;
Emerg Infect Dis; 2021 Sep; 27(9):2349-2359. PubMed ID: 34087089
[TBL] [Abstract][Full Text] [Related]
20. Invasive Mucormycosis and Aspergillosis Coinfection Associated with Post-COVID-19 Pneumonia in a Tertiary Care Hospital.
Paul M; Sasidharan J; Taneja J; Chatterjee K; Abbas SZ; Chowdhury V; Das A
Med Mycol J; 2022; 63(3):59-64. PubMed ID: 36047183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
